Anthony Letai Has Been Appointed the 18th Director of the National Cancer Institute

Anthony Letai

Eric Small: Excited to Share the Next Installment in My Science Matters Series

Eric Small

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Giuseppe Curigliano: The ROME Trial - A National Effort to Bring Genomics to the Heart of Cancer Care in Italy

Giuseppe Curigliano

Sek Kathiresan: Thrilled to Join Eli Lilly and Co. as Senior Vice President

Sek Kathiresan

Transforming Cancer Care with CancerX Accelerator 2026 - CancerX

CancerX

Svetlana Nikic: Navigating CNEDiMTS, RIHN 2.0, and PECT in France’s Precision Oncology Reimbursement

Svetlana Nikic

Paving the Way for a Smoke-Free Generation by 2040 - European Cancer Organisation

European Cancer Organisation

OncoCalendar

« All Events

  • This event has passed.

Exploring a New Generation of Patient-Centric Cancer Clinical Trials by AACR

Jan 21 • 1:00 PM - 2:30 PM
AACR

Exploring a New Generation of Patient-Centric Cancer Clinical Trials by AACR will be held on January 21, 2025, Virtually.

The forum will explore the new generation of patient-centric cancer clinical trials, focusing on how advancements in cancer research will reshape the clinical trial process. As more people are expected to survive and live beyond cancer, largely due to clinical trials, the conference will highlight the ongoing transformation in trial design. The emphasis will be on creating more efficient, inclusive, and patient-focused trials that prioritize patient needs and preferences. This shift will be critical in ensuring broader access to innovative treatments and improving overall patient outcomes.

The upcoming session will feature a group of esteemed experts in the field of cancer research. Jan Tomlinson from the University of California, San Francisco, will share insights from a patient advocate’s perspective on the clinical trial experience. Patricia M. LoRusso, DO, PhD (HC), FAACR, from Yale Cancer Center, will discuss innovative clinical trial designs aimed at improving efficiency and inclusivity. David A. Tuveson, MD, PhD, FAACR, from CSHL Cancer Center, will highlight the Cancer Therapeutics Initiative, which focuses on translating basic research into clinical applications. Laura van ‘t Veer, PhD, from the University of California, San Francisco, will present on the second-generation design of the I-SPY 2 trial, driving advancements in precision medicine. These experts will cover a broad range of topics, all geared toward advancing cancer clinical trials and patient care.

Register Now!

Details

Date:
Jan 21
Time:
1:00 PM - 2:30 PM
Website:
https://www.aacr.org/patients-caregivers/patient-advocacy/aacr-events-for-patient-advocates/aacr-virtual-patient-advocate-forums/exploring-a-new-generation-of-patient-centric-cancer-clinical-trials/

Organizer

American Association for Cancer Research
Phone
215-440-9300
Email
aacr@aacr.org
View Organizer Website